4//SEC Filing
Novus Therapeutics, Inc. 4
Accession 0000899243-17-014539
$ELDNCIK 0001404281operating
Filed
May 25, 8:00 PM ET
Accepted
May 26, 4:05 PM ET
Size
5.6 KB
Accession
0000899243-17-014539
Insider Transaction Report
Form 4
OCAMPO CHRISTINE
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2017-05-24+52,500→ 52,500 totalExercise: $5.50Exp: 2027-05-23→ Common Stock (52,500 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 52,500 shares of the Issuer's Common Stock. 36,000 shares will vest ratably each month over three years beginning on May 24, 2017 (the "grant date"). 16,500 shares will vest on the later of achievement of a performance-related goal or the first anniversary of the grant date.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001404281
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 4:05 PM ET
- Size
- 5.6 KB